Tectonic Therapeutic (TECX) has had the highest return this year by a US stock, returning 5,979,275%.

ASSET	YEAR	% RETURN
Tectonic Therapeutic (TECX)	2024	5,979,275%
Nexalin Technology (NXLIW)	2024	8,350.7%
Iteris (ITI)	2024	5,295.93%
Wearable Devices (WLDSW)	2024	4,328.57%
TSS, Inc Common Stock (TSSI)	2024	3,396.3%
GeneDx (WGS)	2024	2,882.22%
Triller (ILLRW)	2024	2,785.25%
Bright Minds Biosciences (DRUG)	2024	2,457.72%
LENZ Therapeutics (LENZ)	2024	1,969.89%
Sezzle Inc Common Stock (SEZL)	2024	1,940.26%
Primega Group Holdings Limited Ordinary Shares (PGHL)	2024	1,817.14%
Fitell Corporation Ordinary Shares (FTEL)	2024	1,609.87%
BM Technologies Inc WT (BMTX.WT)	2024	1,452.71%
Zivo Bioscience (ZIVO)	2024	1,420.74%
GeneDx (WGSWW)	2024	1,384%
NeoVolta Inc Warrant (NEOVW)	2024	1,353.45%
CompoSecure (CMPOW)	2024	1,281.58%
Codere Online Luxembourg SA Warrants (CDROW)	2024	1,201.27%
FTAC Emerald Acquisition (FLDDW)	2024	1,169.06%
CleanSpark, Inc Warrant (CLSKW)	2024	1,112.46%
Mobiquity Technologies (MOBQ)	2024	1,088.95%
Monopar Therapeutics (MNPR)	2024	1,075.23%
Palladyne AI (PDYNW)	2024	999%
Dave (DAVE)	2024	978.4%
Roth CH Acquisition V Co Warrant (ROCLW)	2024	977.69%